Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst TOIIW 深 滬
已收盤 02-06 16:00:00 美东时间
0.1038
-0.016
-13.50%
華盛通- 最 高0.12
- 今 開0.10
- 成交量 2.38万股
- 最 低 0.10
- 昨 收 0.12
- 總市值 0
- 52周最高 0.2725
- 市盈率 靜 --
- 換手率 Infinity.00%
- 52周最低 0.0175
- 委 比 -33.78%
- 總股本 --
- 歷史最高 3.86
- 量 比 6.66
- 振 幅 16.67%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多The Oncology Institute reaffirms 2025 guidance, projects 2026 revenue
The Oncology Institute (TOI) on Monday reaffirmed its 2025 financial guidance and provided its preliminary 2026 outlook, expecting total revenue of $630 million to $650 million, up about 28% from the ...
01-12 21:36
The Oncology Institute Announces Addition of Board Member Mark Stolper
The Oncology Institute, Inc. (TOI) announced the addition of Mark Stolper to its Board of Directors. As RadNet’s CFO and executive vice president, and with extensive healthcare leadership experience, Stolper brings valuable expertise in capital markets and strategic planning to TOI. TOI expects his insights to drive future growth and profitability. Stolper expressed enthusiasm for TOI’s mission to deliver advanced, cost-effective cancer care.
01-05 13:30
The Oncology Institute Announces Resignation of Board Member Gabe Ling
The Oncology Institute, Inc. (TOI) announced that Gabe Ling resigned from its Board of Directors as of December 1, 2025. The company has initiated a search for new independent directors with expertise in healthcare, clinical, and value-based care. The Board expressed gratitude to Ling for his contributions during TOI's development and emphasized its commitment to strengthening governance and achieving long-term growth goals. Founded in 2007, TOI ...
2025-12-01 13:30
Oncology Institute Projects Strong 2025 Revenue Growth
Oncology Institute ( ($TOI) ) just unveiled an update. The Oncology Institute h...
2025-11-14 19:46
The Oncology Institute Q3 EPS $(0.14) Misses $(0.11) Estimate, Sales $136.564M Beat $122.633M Estimate
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.11) by 23.89 percent. This is a 22.22 percent increase over losses of $(0.18) per
2025-11-14 05:08
Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration
Healthcare tech company Ascertain and The Oncology Institute partnered to develop a "near-touchless" administrative system, reducing manual interactions between providers and payers. Their collaboration focused on Ascertain's Unified Payer Portal (UPP), an AI-powered tool automating pre-visit tasks for outpatient oncology, cutting authorization submission time by over 80% and saving up to $2 million annually. The system, deployed in eight weeks, ...
2025-11-13 21:04
The Oncology Institute Reports Cyber Incident At IT Vendor Causing Minor Delay In Fee-For-Service Collections; Says No Evidence Of Patient Data Compromise In Incident
On November 3, 2025, The Oncology Institute, Inc. (the "Company") determined that a cybersecurity incident affecting an information technology software provider would potentially delay fee-for-service collections. Based
2025-11-07 07:21
The Oncology Institute shares are trading lower after the company reported mixed Q2 financial results.
The Oncology Institute shares are trading lower after the company reported mixe...
2025-08-14 23:57
The Oncology Institute Named Exclusive Oncology Provider For 80K SilverSummit Medicaid Patients In Nevada Starting July 1, 2025
The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI"), one of the largest value-based oncology groups in the United States, announced today that effective July 1, it will be the exclusive oncology provider for over 80,000
2025-07-01 04:09
Oncology Institute Explores PIPE Financing Opportunity
An announcement from Oncology Institute ( ($TOI) ) is now available. The Oncolo...
2025-05-20 05:31
